Theravance BiopharmaTBPH
那斯達克 · USD
17.06
+0.01
(+0.03%)
盤中 09/23 12:48 (UTC+8)
09/23 12:48 (UTC+8)
Theravance BiopharmaTBPH
17.06
+0.01
(+0.03%)
財務數據
損益表
- 0.15
- 0.14
- 0.17
- 0.19
- 0.15
- 0.26
- 0.20
- 0.46
- 0.18
- 0.21
- -17.43
- -1.70
- 18.32
- 11.18
- -17.95
- 70.23
- -23.69
- 129.57
- -61.43
- 17.13
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 20,731 | 17,699 | 45,891 | 19,990 | 26,195 | 15,388 | 18,754 | 16,868 | 14,256 | 14,503 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 20,731 | 17,699 | 45,891 | 19,990 | 26,195 | 15,388 | 18,754 | 16,868 | 14,256 | - |
營業費用 | 29,008 | 27,182 | 25,880 | 26,444 | 28,920 | 29,822 | 27,954 | 27,705 | 29,961 | - |
研發費用 | 4,712 | 5,829 | 7,360 | 8,112 | 10,490 | 11,452 | 9,453 | 9,268 | 9,954 | 8,968 |
推銷及管理費用 | 20,265 | 17,720 | 18,520 | 18,332 | 18,430 | 18,370 | 18,501 | 16,875 | 17,056 | 16,742 |
非經常性項目費用 | 4,031 | 3,633 | - | - | - | - | - | 1,562 | 2,951 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 1,843 | -9,483 | 20,011 | -6,454 | -2,725 | -14,434 | -9,200 | -10,837 | -15,705 | -11,207 |
其他收入及費用 | 3,486 | 3,013 | 53,639 | 4,138 | 76,594 | 939 | 904 | 1,415 | 1,128 | 1,434 |
利息費用 | - | - | 582 | 573 | 663 | 643 | 643 | 630 | 644 | 629 |
稅前純益 | -4,791 | -6,470 | 73,068 | -2,889 | 73,206 | -14,138 | -8,939 | -10,052 | -15,221 | -10,402 |
所得稅 | 1,107 | -1,537 | 12,044 | -6,504 | 18,371 | -559 | 6,588 | 2,646 | 1,308 | 1,262 |
稅後純益 | -5,898 | -4,933 | 61,024 | 3,615 | 54,835 | -13,579 | -15,527 | -12,698 | -16,529 | -11,664 |
基本每股稅後盈餘(元) | -0.11 | -0.10 | 1.20 | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 |
稀釋每股稅後盈餘(元) | -0.11 | -0.10 | 1.18 | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 |
基本平均股數(千股) | 51667.00 | 51279.00 | 50868.00 | 50520.00 | 50177.00 | 49706.00 | 49306.00 | 49038.00 | 48747.00 | 48283.00 |
稀釋平均股數(千股) | 51667.00 | 51279.00 | 53053.00 | 51908.00 | 50726.00 | 49706.00 | 49306.00 | 49038.00 | 48747.00 | 48283.00 |
還原基本每股稅後盈餘(元) | -0.11 | -0.10 | 1.20 | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 |
還原稀釋每股稅後盈餘(元) | -0.11 | -0.10 | 1.18 | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 |
還原基本平均股數(千股) | 51,667 | 51,279 | 50,868 | 50,520 | 50,177 | 49,706 | 49,306 | 49,038 | 48,747 | 48,283 |
還原稀釋平均股數(千股) | 51,667 | 51,279 | 53,053 | 51,908 | 50,726 | 49,706 | 49,306 | 49,038 | 48,747 | 48,283 |
EBITDA(千元) | -4,285 | -5,635 | 73,846 | -1,680 | 74,796 | -12,443 | -7,601 | -8,660 | -13,598 | -8,594 |